Overview

Rapid Benzodiazepine Detoxification Using Flumazenil - 1

Status:
Completed
Trial end date:
1994-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Flumazenil